Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
09/25/2012 | US8273733 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
09/25/2012 | US8273341 Antiviral compounds |
09/25/2012 | CA2641744C Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
09/25/2012 | CA2560071C Lysine based compounds |
09/20/2012 | WO2012125981A2 Raf kinase inhibitors |
09/20/2012 | WO2012125629A1 Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors |
09/20/2012 | WO2012124775A1 Nitrogen-containing saturated heterocyclic compound |
09/20/2012 | WO2012124750A1 Azole derivative |
09/20/2012 | WO2012124744A1 Nitrogen-containing condensed heterocyclic compound |
09/20/2012 | WO2012124696A1 Guanidine compound |
09/20/2012 | WO2012123563A1 Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
09/20/2012 | WO2012123522A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
09/20/2012 | WO2012123468A1 New azaspirodecanone compounds |
09/20/2012 | WO2012123467A1 Pyrimidine amide compounds |
09/20/2012 | WO2012123311A1 Pyridinyl- and pyrazinyl -methyloxy - aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
09/20/2012 | WO2012099736A3 Improved process for preparation of high molecular weight molybdenum succinimide complexes |
09/20/2012 | WO2012097173A3 Substituted benzoazepines as toll-like receptor modulators |
09/20/2012 | US20120238752 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production |
09/20/2012 | US20120238676 Use of oligomeric carbodiimides as stabilizers |
09/20/2012 | US20120238594 Azaspirodecanone compounds |
09/20/2012 | US20120238582 Quinazoline derivatives |
09/20/2012 | US20120238581 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
09/20/2012 | US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels |
09/20/2012 | US20120238577 Prostaglandin transporter inhibitors and uses thereof |
09/20/2012 | US20120238576 Triazine Derivatives and their Therapeutical Applications |
09/20/2012 | US20120238570 Inhibitors of the hedgehog pathway |
09/20/2012 | US20120238559 Novel compounds |
09/20/2012 | US20120238551 Substituted Phenoxypropylcycloamine Derivatives as Histamine-3 (H3) Receptor Ligands |
09/20/2012 | US20120238550 Compound |
09/20/2012 | US20120238540 Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1 |
09/20/2012 | US20120238539 Novel piperazine analogs as broad-spectrum influenza antivirals |
09/20/2012 | US20120237475 Novel Inhibitors |
09/20/2012 | US20120235129 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
09/20/2012 | CA2830157A1 Guanidine compound |
09/20/2012 | CA2830115A1 New azaspirodecanone compounds |
09/20/2012 | CA2829746A1 Azole derivative |
09/20/2012 | CA2828518A1 Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
09/20/2012 | CA2828378A1 Nitrogen-containing saturated heterocyclic compound |
09/20/2012 | CA2827161A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
09/19/2012 | EP2499134A2 Oxygen scavengers, composition comprising the scavengers, and articles made from the compositions |
09/19/2012 | EP2499133A2 Process for the preparation of crystalline form i of l-malic acid salt of sunitinib |
09/19/2012 | EP2499132A1 Hepatitis c virus inhibitors |
09/19/2012 | EP2499131A2 Crystalline forms of bosentan salts and processes for their preparation |
09/19/2012 | EP2499130A1 Novel diazinylpyrazolyl compounds |
09/19/2012 | EP2499129A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
09/19/2012 | EP2499128A1 Crystalline cdc7 inhibitor salts |
09/19/2012 | EP2499127A1 Hepatitis c virus inhibitors |
09/19/2012 | EP2499121A1 Oxazoline derivatives for treatment of cns disorders. |
09/19/2012 | EP2499117A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
09/19/2012 | EP2498607A1 Kinase inhibitors |
09/19/2012 | CN102686590A Pyrazoline dione derivatives as NADPH oxidase inhibitors |
09/19/2012 | CN102686581A Novel quinazoline derivatives |
09/19/2012 | CN102686580A Imidazole derivative as casein kinase inhibitors |
09/19/2012 | CN102686579A Compounds and compositions as modulators of GPR119 activity |
09/19/2012 | CN102686572A Oxazoline derivatives for treatment of CNS disorders |
09/19/2012 | CN102686569A Phenoxy-substituted pyrimidines as opioid receptor modulators |
09/19/2012 | CN102686564A 吡咯烷衍生物 Pyrrolidine derivative |
09/19/2012 | CN102675401A Preparation of anti-tumor medicine LQC-Y and application thereof |
09/19/2012 | CN102675296A Bipolar material organic electroluminescent device and preparation method thereof |
09/19/2012 | CN102675295A Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative |
09/19/2012 | CN102675294A Method of synthesizing losartan and losartan intermediates |
09/19/2012 | CN102675293A Indole diketopiperazines derivatives, preparation method and application thereof |
09/19/2012 | CN102675292A Indolone derivative, medicinal composition thereof and preparation method and application of indolone derivative |
09/19/2012 | CN102675290A Bicyclic dihydropyrazole compounds |
09/19/2012 | CN102675280A Trifluoromethyl-containing indole ketone compound, and preparation method and application thereof |
09/19/2012 | CN102675224A 2-substituent-7-fluorine-4-aromatic mixed base quinazoline derivant and preparation method and use thereof |
09/18/2012 | US8269002 Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
09/18/2012 | US8268997 Phenyl-substituted 1,3,5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component |
09/18/2012 | US8268879 3-3-di-substituted-oxindoles as inhibitors of translation initiation |
09/18/2012 | US8268852 Heterocyclic inhibitors of MEK and methods of use thereof |
09/18/2012 | US8268842 Fused ring 4-oxopyrimidine derivative |
09/18/2012 | US8268841 Phosphonoxy quinazoline derivatives and their pharmaceutical use |
09/18/2012 | US8268833 Inhibitors of histone deacetylase |
09/18/2012 | US8268829 Substituted pyrimidines useful as protein kinase inhibitors |
09/18/2012 | US8268826 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV |
09/18/2012 | US8268815 Pyrimidine compounds and use thereof |
09/18/2012 | US8268809 Kinase inhibitors for preventing or treating pathogen infection and method of use thereof |
09/18/2012 | US8268751 Combination of active substances with insecticidal properties |
09/18/2012 | US8268750 Combination of active substances with insecticidal properties |
09/18/2012 | US8268459 Benzanthracene compound and organic electroluminescence device using the same |
09/18/2012 | CA2560669C Pyrrolidine-3,4-dicarboxamide derivatives |
09/18/2012 | CA2546002C 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
09/18/2012 | CA2521069C Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
09/13/2012 | WO2012122077A1 Primary amine diazeniumdiolate heterocyclic derivatives |
09/13/2012 | WO2012121992A1 Mst1 kinase inhibitors and methods of their use |
09/13/2012 | WO2012121682A2 Anti-folate antimalarials with dual-binding modes and their preparation |
09/13/2012 | WO2012121561A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
09/13/2012 | WO2012120234A1 Exposure kit including a fluorescent agent and a cyanoacrylate, and method for the co-fumigation of a fluorescent agent and a cyanoacrylate |
09/13/2012 | WO2012120195A1 New pyridazinone and pyridone compounds |
09/13/2012 | WO2012119559A1 Androgen receptor antagonists and uses thereof |
09/13/2012 | WO2012119506A1 Indolone derivatives, pharmaceutical compositions thereof, and preparation methods and applications thereof |
09/13/2012 | WO2012119458A1 Synthesis and use of antitumor drug lqc-y |
09/13/2012 | WO2012099734A3 Improved process for preparation of low molecular weight molybdenum succinimide complexes |
09/13/2012 | WO2012074437A3 Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for the production and use thereof |
09/13/2012 | WO2011103524A8 Cyclic tetrapeptides and therapeutic applications thereof |
09/13/2012 | WO2011100838A8 Derivatives of 1-phenyl-1,5-dihydro-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication |
09/13/2012 | US20120232463 De novo synthesis of bacteriochlorins |
09/13/2012 | US20120232287 Detergent dispersant and lubricating oil composition |
09/13/2012 | US20120232285 Sulfonyl-1,2,4-triazole salts |
09/13/2012 | US20120232283 Process for production of biphenyl derivative |